QMS Medical Allied Services LimitedQMSMEDICorporate

Medical Equipment & Supplies Latest results: Jun 2026 10 quarters of data

₹171.06

MCap ₹331 Cr · P/E 26.0

QMS Medical Allied Services Limited — Stock analysis & AI research QMS Medical Allied Services Limited — Seasonality — best & worst months QMS Medical Allied Services Limited — Technical setup — score, trend, support & resistance QMS Medical Allied Services Limited — Live exchange announcements

📈 SuperTrend Bearish Signal 📈 Relative Strength Leaders 📈 Volume Dry-Up Stocks 📈 Multi-Timeframe Bullish Stocks 📈 Accumulation (OBV Rising) 🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹57 Cr

Sales · Jun 2026

+22.3% YoY

₹8 Cr

Operating Profit · Jun 2026

+29.0% YoY

14.6%

OPM % · Jun 2026

+5.0% YoY

₹4 Cr

Net Profit · Jun 2026

+25.5% YoY

₹2.05

EPS · Jun 2026

+25.0% YoY

📝 QMS Medical Allied Services Limited — results explained

Quarter ended June 2026 (Q1 FY27)

QMS Medical Allied Services Limited reported revenue of ₹57 crore for the quarter ended June 2026 (Q1 FY27), up 22.3% from ₹46 crore in the same quarter last year, and up 28.0% sequentially over the March 2026 quarter.

Net profit rose 25.5% year-on-year to ₹4 crore, from ₹3 crore. Earnings per share (EPS) came in at ₹2.05.

Operating profit stood at ₹8 crore — an operating margin (OPM) of 14.6%, compared with 13.9% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, QMS Medical Allied Services Limited posted revenue of ₹173 crore, a growth of 37.6% over FY25, with a net profit of ₹12 crore (up 5.5% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹183 crore with a net profit of ₹13 crore.

Valuation snapshot

At the current price of ₹171.06, QMSMEDI has a market capitalisation of ₹331 crore and a trailing P/E of about 26.0.

Within the Medical Equipment & Supplies industry, it is the 6th-largest of the 13 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 68.11%, foreign institutional investors (FIIs) 0.00%, domestic institutional investors (DIIs) 1.59%, public shareholders 30.30% of QMS Medical Allied Services Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹331 Cr

Current Price ?

₹171.1

P/E ?

26.00below ind

Industry P/E ?

26.90

P/B ?

3.18

P/S ?

1.81

P/FCF ?

17.41

Enterprise Value ?

₹399 Cr

EV/EBITDA ?

14.38

PEG ?

N/A

Earnings Yield ?

5.8%

Dividend Yield ?

0.29%

Profitability & Returns

Sales (TTM) ?

₹183 Cr

OPM ?

15.1%

Profit after tax (TTM) ?

₹13 Cr

EPS (TTM) ?

₹6.58

ROCE ?

13.0%

ROE ?

12.2%

ROA ?

6.0%

Growth

Sales — latest qtr ?

₹57 Cr

PAT — latest qtr ?

₹4 Cr

YoY qtr sales growth ?

22.3%

YoY qtr profit growth ?

25.5%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹68 Cr

Debt to Equity ?

0.65

Interest Coverage ?

3.3

Current Ratio ?

N/A

Ownership

Promoter holding ?

68.11%

Change in promoter holding ?

-5.56%

Pledged percentage ?

N/A

Market

Return 3 months ?

55.8%

Return 6 months ?

116.5%

🗓️ Quarterly results (10 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Dec 2023	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	35	32	37	44	45	46	45	37	44	57	+22.3%	+28.0%
Operating Profit	5	4	7	7	6	6	7	7	6	8	+29.0%	+44.2%
Other Income	0	0	0	0	1	0	0	0	0	0	+30.8%	+89.9%
Interest	1	1	1	1	1	1	1	2	2	2	+20.2%	-15.3%
Depreciation	1	1	1	1	1	1	1	1	1	1	+71.0%	+31.0%
Profit Before Tax	3	2	6	5	5	4	5	4	3	6	+23.8%	+95.4%
Net Profit	2	2	4	3	4	3	4	3	2	4	+25.5%	+95.9%
EPS	1.26	0.80	1.78	1.63	1.73	1.64	1.71	1.24	0.89	2.05	+25.0%	+130.3%
OPM %	13.7%	12.2%	19.5%	15.8%	14.3%	13.9%	15.5%	18.1%	13.0%	14.6%	+5.0%	+12.3%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹126 Cr	₹173 Cr	₹183 Cr	+37.6%
Operating Profit	₹21 Cr	₹26 Cr	₹28 Cr	+25.8%
OPM %	16.36%	14.97%	15.14%	-8.5%
NPM %	8.99%	6.89%	6.94%	-23.4%
Other Income	₹2 Cr	₹1 Cr	₹1 Cr	-34.6%
Depreciation	₹3 Cr	₹4 Cr	₹5 Cr	+28.7%
Interest	₹4 Cr	₹7 Cr	₹7 Cr	+72.6%
EBIT	₹17 Cr	₹22 Cr	₹23 Cr	+25.4%
PBT	₹15 Cr	₹16 Cr	₹18 Cr	+7.3%
Tax	₹1 Cr	₹4 Cr	₹4 Cr	+142.9%
Net Profit	₹11 Cr	₹12 Cr	₹13 Cr	+5.5%
EPS	₹5.14	₹5.48	₹5.89	+6.6%
Material Cost	₹24 Cr	₹79 Cr	₹81 Cr	+235.8%
Employee Cost	₹3 Cr	₹9 Cr	₹17 Cr	+229.0%
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 3 periods)

Metric	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	18	18	19	+5.6%
Reserves	61	72	85	+18.1%
Borrowings	35	60	68	+13.3%
Other Liabilities	22	40	41	+2.5%
Total Liabilities	135	190	213	+12.1%
Fixed Assets	24	53	57	+7.5%
CWIP	2	3	0	-100.0%
Investments	2	3	5	+66.7%
Other Assets	108	131	150	+14.5%
Total Assets	135	190	213	+12.1%

💧 Cash Flow (latest 3 periods)

Metric	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	1	20	19	-5.0%
Cash from Investing Activity	-3	-45	-20	+55.6%
Cash from Financing Activity	0	26	1	-96.2%
Net Cash Flow	-1	1	0	-100.0%
Free Cash Flow	1	20	19	-5.0%
CFO/OP	26%	101%	93%	-7.9%

➗ Ratios (latest 3 periods)

Metric	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	124	101	142	+40.6%
Inventory Days	172	176	181	+2.8%
Days Payable	90	76	73	-3.9%
Cash Conversion Cycle	205	202	250	+23.8%
Working Capital Days	148	100	105	+5.0%
ROCE %	—	17%	13%	-23.5%

👥 Shareholding (latest 4 periods)

Metric	Mar 2025	Jun 2025	Sep 2025	Mar 2026	% Chg
Promoters	73.67%	73.67%	68.11%	68.11%	+0.0%
FIIs	0.01%	0.01%	0.01%	0.00%	-100.0%
DIIs	0.00%	0.00%	1.60%	1.59%	-0.6%
Public	26.33%	26.33%	30.28%	30.30%	+0.1%
No. of Shareholders	1,519	1,489	1,564	1,499	-4.2%

⚖️ Peer comparison

Industry: Medical Equipment & Supplies · 13 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	FISCHER Fischer Medical	₹33.50	2,293	85.2	367	24	12.3%	6.7%	178.6%	2051.4%	249.4%	-24.3%
2	TARSONS Tarsons Products	₹330.00	1,756	157.9	441	11	27.0%	2.5%	-66.3%	-81.4%	20.7%	-181.0%
3	DENTALKART Vasa Denticity	₹563.10	977	80.0	299	12	4.4%	4.0%	16.7%	-28.5%	12.9%	-2.9%
4	543916 Hemant Surgical	₹193.85	544	13.9	231	18	10.4%	7.8%	—	—	187.9%	160.0%
5	543363 Prevest Denpro	₹616.50	456	32.8	75	23	35.7%	29.9%	13.6%	17.6%	23.7%	24.8%
6	QMSMEDI QMS Medical	₹185.89	359	52.7	162	7	13.1%	4.1%	5.1%	-47.9%	23.7%	-0.8%
7	NURECA Nureca	₹331.55	331	75.9	153	4	2.7%	2.8%	34.0%	146.7%	18.0%	277.2%
8	530427 Choksi Asia	₹65.64	122	7.2	47	5	14.5%	11.1%	61.1%	173.2%	-22.5%	-10.1%
9	527005 Shree Pacetronix	₹168.25	55	19.2	21	3	24.8%	15.3%	28.7%	324.3%	-8.3%	14.5%
10	544143 Royal Sense	₹139.00	47	24.7	38	3	12.8%	8.0%	—	—	2.5%	-5.4%
11	533212 GKB Ophthalmics	₹104.90	32	17.6	150	6	7.0%	3.7%	36.8%	142.7%	2.3%	388.5%
12	531380 Centenial Surgical	₹110.90	27	—	56	-1	10.7%	-2.6%	0.6%	-38.1%	18.6%	1937.8%
13	542765 Transpact Enterprises	₹325.00	4	140.1	0	0	63.2%	47.4%	—	—	12.5%	-20.0%

❓ Frequently asked questions

What was QMS Medical Allied Services Limited's revenue in Q1 FY27?

What was QMS Medical Allied Services Limited's net profit in Q1 FY27?